News

TrialScope, a clinical trial transparency and compliance solutions provider, announced the availability of Convert, a free online clinical trial data conversion service.

Throughout this trial, YPrime will be supporting world class selected sites to conduct the study with data driven metrics pulled from these tools. YPrime is dedicated to applying its leading edge eClinical technology to help forward unmet medical needs in the Biotech and Pharmaceutical industry.

Triumph Research Intelligence (TRI), based in London, UK and Raleigh, NC announces its Risk-Based Monitoring platform, Operational Platform for Review, Reporting and Analysis OPRA, for a combination of statistical calculations, data visualizations and operational activity management.

Certara®, a global biosimulation technology-enabled consultancy, announced version 2.0 of its Cardiac Safety Simulator (CSS), which has become a standalone product for the first time. CSS is an alternative to Thorough QT/QTc (TQT) studies.

Evaluating the use of new tumor measurement tools for studies of molecular-targeted cancer therapies.

Faster go/no-go decisions is the primary driver of adaptive-design adoption by sponsors.

Initiative designed to boost understanding of medical device development in Europe.

Patient focused drug development is playing a larger role in study design and outcome measurement.

New ASCO study evaluating the cancer care system reveals mixed findings.

Outlining the requirements and benefits of FDA's four expedited drug approval pathways.

Following four key study-design steps is crucial to the delivery of a successful cross-border cancer study

Trial Design: Breaking Blood Cancer Barriers Adaptive Solutions in Oncology Clinical Technology: Tumor Imaging Ascension Sites: Enrollment Forecast Data Also in this issue: Innovation Initiative Debate in Europe R&D Investment: Public vs. Private The Psychology of Cancer

The European Medicines Agency (EMA), along with the Heads of Medicines Agencies (HMA), have published the ‘EU Medicines Agencies Network Strategy to 2020.

PAREXEL introduced the latest version of its Regulatory Information Management (RIM) platform: LIQUENT InSight® 6.0

Biorasi, a full-service CRO, announced a strategic partnership with Medidata, where it has deployed Medidata's electronic data capture (EDC), management and reporting system, Medidata Rave®, to support Biorasi's Phase I through IV global clinical trial business.

Quintiles and Quest Diagnostics announced a definitive agreement to form a global clinical trials laboratory services business.

Scholarship Program Helps Address Site Sustainability through Education and Training Provides Sites Access to SCRS Member Benefits

Biologic drugs and non-biologic complex drugs have revolutionized the treatment of many difficult-to-treat diseases including cancer, multiple sclerosis, and chronic iron deficiency.

The Society for Clinical Research Sites (SCRS), a global trade organization representing the interests of clinical research sites, announced a two-year partnership with PRA Health Sciences.